The Wrong Investor Can Sink Your Startup, Says Black Ops VC Partner

Venture capital is not a loan — every dollar a founder raises buys an investor a seat of ownership, and potentially a board seat with influence over fundraising, acquisitions and leadership changes. That structural reality is why Antonia Dean, partner at early-stage firm Black Operator Ventures (Black Ops VC), argues that founders are making a mistake when they treat a term sheet as the finish line.

"You're not simply raising money, you're also deciding who will sit at the table you're building," writes Dean, who is also founder of The Antonia Method, a strategic advisory and risk-management framework for CEOs and senior leaders.

Her argument, laid out in a commentary for Crunchbase News, is direct: fundraising is grueling — dozens of pitches, follow-ups and rejections — and founders instinctively chase the biggest check at the highest valuation. But the strongest cap tables are not filled with whoever was willing to invest. They are intentionally constructed around investors who bring three distinct forms of value.

Investors who open doors you cannot

The phrase "investors should bring more than money" has become a fundraising cliché, Dean concedes. Her test cuts through it: founders should ask of every potential investor, "What can they materially help this company accomplish over the next 18 to 24 months?"

The answer looks different by sector. A fintech investor should deliver introductions to banks, regulators, payment companies or enterprise customers. A healthcare investor should provide access to hospital systems, insurers or executives who understand lengthy procurement cycles. A consumer investor should know distribution, retail partnerships and customer acquisition.

The value shows up most clearly when things go wrong. When growth stalls, a key hire leaves or a partnership disappears, Dean writes, "the investor who can introduce five potential customers on Monday is significantly more useful than one whose primary contribution was wiring money six months earlier."

Her practical advice: founders should diligence investors the way investors diligence them. Ask what platform support typically entails. Talk to portfolio founders. Find out whether the investor was useful when the company struggled. "Reputation and access should be proven, not promised," Dean writes.

Investors who understand the exact stage

A billion-dollar growth fund's brand does not translate into help for a company with six employees, an unfinished product and nine months of runway, Dean argues. Startup problems shift sharply by stage.

At pre-seed, founders are still validating the market and hunting for product-market fit. At seed, the challenge becomes hiring, repeatability and proving customers will consistently pay. By Series A, investors expect evidence the company can scale what already works.

Investors who repeatedly work with companies at the same point in their development have "seen the movie before," Dean writes. They know which metrics the next round of investors will examine, which mistakes derail companies, and what milestones founders should prioritize before returning to market. They also hold something founders will not find in a database: current fundraising intelligence.

Dean points to platforms like Crunchbase, which combines past financing data with predictions designed to surface company momentum, as a complement to that firsthand perspective. But her bottom line on selection is blunt: "The best investor isn't necessarily the person with the biggest fund. Sometimes it is the person who knows exactly what your company needs to look like 12 months from now."

At least one investor you can tell the truth

The most overlooked investor may be the most important: someone the founder actually trusts. Revenue misses projections. Co-founders disagree. Executives quit. Products fail. Fundraising takes longer than expected. In those moments, Dean writes, founders need someone they can call before the polished explanation is ready — an investor who "gets" them, not simply their market or business model, but how they operate as a person.

That relationship carries particular weight for founders navigating rooms where few investors share their background. A trusted investor can interpret dynamics, help prepare for difficult conversations and give candid advice "without making every mistake feel like an indictment of the founder's ability to lead."

Fundraising behavior itself offers the clues, Dean argues. Do investors listen? Do they respect the founder's judgment? Can they disagree without becoming dismissive? Do portfolio founders call them when things go badly, or only with good news?

The so-what

Dean's framework sets a clear pre-close checklist: before signing, founders should confirm their cap table contains all three forms of support — someone who knows the industry, someone who understands the stage, and someone they genuinely trust. Her closing warning carries the practical stakes for any founder weighing multiple term sheets: capital can help build a company, but the wrong capital can make building it substantially harder.